nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—CASK—Syndecan-1-mediated signaling events—COL1A1—otosclerosis	0.0191	0.0391	CbGpPWpGaD
Bosutinib—FYN—Reelin signaling pathway—RELN—otosclerosis	0.0126	0.0258	CbGpPWpGaD
Bosutinib—SRMS—Focal Adhesion—RELN—otosclerosis	0.0124	0.0254	CbGpPWpGaD
Bosutinib—PDGFRB—Osteoblast Signaling—COL1A1—otosclerosis	0.0122	0.025	CbGpPWpGaD
Bosutinib—ABL1—Lissencephaly gene (LIS1) in neuronal migration and development—RELN—otosclerosis	0.0117	0.024	CbGpPWpGaD
Bosutinib—SIK2—connective tissue—otosclerosis	0.011	0.0214	CbGeAlD
Bosutinib—FES—IL4-mediated signaling events—COL1A1—otosclerosis	0.0108	0.0222	CbGpPWpGaD
Bosutinib—TXK—Focal Adhesion—RELN—otosclerosis	0.0106	0.0216	CbGpPWpGaD
Bosutinib—TNK2—Focal Adhesion—RELN—otosclerosis	0.0103	0.0211	CbGpPWpGaD
Bosutinib—SRMS—connective tissue—otosclerosis	0.00998	0.0195	CbGeAlD
Bosutinib—SYK—connective tissue—otosclerosis	0.00959	0.0187	CbGeAlD
Bosutinib—CDK2—connective tissue—otosclerosis	0.0095	0.0186	CbGeAlD
Bosutinib—PTK2—Nanoparticle-mediated activation of receptor signaling—COL1A1—otosclerosis	0.00935	0.0191	CbGpPWpGaD
Bosutinib—CASK—Syndecan interactions—TGFB1—otosclerosis	0.00906	0.0186	CbGpPWpGaD
Bosutinib—CSF1R—Integrins in angiogenesis—COL1A1—otosclerosis	0.00861	0.0176	CbGpPWpGaD
Bosutinib—PLK2—connective tissue—otosclerosis	0.00837	0.0164	CbGeAlD
Bosutinib—ALK—Differentiation Pathway—TGFB1—otosclerosis	0.00821	0.0168	CbGpPWpGaD
Bosutinib—STK4—connective tissue—otosclerosis	0.008	0.0156	CbGeAlD
Bosutinib—TLK1—tendon—otosclerosis	0.00775	0.0152	CbGeAlD
Bosutinib—PRKCQ—tendon—otosclerosis	0.00764	0.0149	CbGeAlD
Bosutinib—ALK—connective tissue—otosclerosis	0.00756	0.0148	CbGeAlD
Bosutinib—TYRO3—connective tissue—otosclerosis	0.00756	0.0148	CbGeAlD
Bosutinib—LYN—connective tissue—otosclerosis	0.00752	0.0147	CbGeAlD
Bosutinib—BTK—connective tissue—otosclerosis	0.00737	0.0144	CbGeAlD
Bosutinib—BMPR2—ALK1 signaling events—TGFB1—otosclerosis	0.00735	0.015	CbGpPWpGaD
Bosutinib—MAP2K2—Nanoparticle-mediated activation of receptor signaling—COL1A1—otosclerosis	0.0072	0.0147	CbGpPWpGaD
Bosutinib—CLK3—tendon—otosclerosis	0.00717	0.014	CbGeAlD
Bosutinib—PHKG1—tendon—otosclerosis	0.00701	0.0137	CbGeAlD
Bosutinib—ROCK1—connective tissue—otosclerosis	0.00698	0.0136	CbGeAlD
Bosutinib—EIF2AK1—tendon—otosclerosis	0.00693	0.0136	CbGeAlD
Bosutinib—BMPR2—connective tissue—otosclerosis	0.00678	0.0132	CbGeAlD
Bosutinib—MAP2K1—Nanoparticle-mediated activation of receptor signaling—COL1A1—otosclerosis	0.00673	0.0138	CbGpPWpGaD
Bosutinib—VRK2—tendon—otosclerosis	0.00672	0.0131	CbGeAlD
Bosutinib—FES—tendon—otosclerosis	0.00672	0.0131	CbGeAlD
Bosutinib—SRMS—Focal Adhesion—COL1A1—otosclerosis	0.00667	0.0137	CbGpPWpGaD
Bosutinib—SYK—tendon—otosclerosis	0.00659	0.0129	CbGeAlD
Bosutinib—TNIK—tendon—otosclerosis	0.00659	0.0129	CbGeAlD
Bosutinib—CDK2—tendon—otosclerosis	0.00653	0.0128	CbGeAlD
Bosutinib—MAP4K4—connective tissue—otosclerosis	0.00652	0.0128	CbGeAlD
Bosutinib—STK26—tendon—otosclerosis	0.00647	0.0126	CbGeAlD
Bosutinib—MAP2K1—connective tissue—otosclerosis	0.0063	0.0123	CbGeAlD
Bosutinib—CSK—connective tissue—otosclerosis	0.00626	0.0122	CbGeAlD
Bosutinib—CHEK2—tendon—otosclerosis	0.00625	0.0122	CbGeAlD
Bosutinib—WEE1—tendon—otosclerosis	0.0062	0.0121	CbGeAlD
Bosutinib—DMPK—tendon—otosclerosis	0.0062	0.0121	CbGeAlD
Bosutinib—CLK1—connective tissue—otosclerosis	0.00618	0.0121	CbGeAlD
Bosutinib—PTK2B—Integrins in angiogenesis—COL1A1—otosclerosis	0.00614	0.0126	CbGpPWpGaD
Bosutinib—BMP2K—connective tissue—otosclerosis	0.00606	0.0119	CbGeAlD
Bosutinib—STK25—tendon—otosclerosis	0.00592	0.0116	CbGeAlD
Bosutinib—ROCK1—Integrins in angiogenesis—COL1A1—otosclerosis	0.00591	0.0121	CbGpPWpGaD
Bosutinib—PTK2B—connective tissue—otosclerosis	0.00586	0.0114	CbGeAlD
Bosutinib—EGFR—Nanoparticle-mediated activation of receptor signaling—COL1A1—otosclerosis	0.00585	0.012	CbGpPWpGaD
Bosutinib—RPS6KB1—IL4-mediated signaling events—COL1A1—otosclerosis	0.00577	0.0118	CbGpPWpGaD
Bosutinib—PLK2—tendon—otosclerosis	0.00575	0.0112	CbGeAlD
Bosutinib—SIK3—tendon—otosclerosis	0.00571	0.0112	CbGeAlD
Bosutinib—RPS6KB1—Integrins in angiogenesis—COL1A1—otosclerosis	0.0057	0.0117	CbGpPWpGaD
Bosutinib—SIK1—connective tissue—otosclerosis	0.00567	0.0111	CbGeAlD
Bosutinib—TXK—Focal Adhesion—COL1A1—otosclerosis	0.00567	0.0116	CbGpPWpGaD
Bosutinib—CASK—Syndecan-2-mediated signaling events—TGFB1—otosclerosis	0.00566	0.0116	CbGpPWpGaD
Bosutinib—ERBB3—connective tissue—otosclerosis	0.00556	0.0109	CbGeAlD
Bosutinib—TNK2—Focal Adhesion—COL1A1—otosclerosis	0.00553	0.0113	CbGpPWpGaD
Bosutinib—MAP3K2—connective tissue—otosclerosis	0.00551	0.0108	CbGeAlD
Bosutinib—CAMK1D—tendon—otosclerosis	0.00544	0.0106	CbGeAlD
Bosutinib—CASK—Syndecan-1-mediated signaling events—TGFB1—otosclerosis	0.00542	0.0111	CbGpPWpGaD
Bosutinib—PTK2—connective tissue—otosclerosis	0.00539	0.0105	CbGeAlD
Bosutinib—STK24—tendon—otosclerosis	0.00537	0.0105	CbGeAlD
Bosutinib—LCK—Inflammatory Response Pathway—COL1A1—otosclerosis	0.00533	0.0109	CbGpPWpGaD
Bosutinib—FER—tendon—otosclerosis	0.0052	0.0102	CbGeAlD
Bosutinib—RPS6KB1—connective tissue—otosclerosis	0.00519	0.0101	CbGeAlD
Bosutinib—AXL—connective tissue—otosclerosis	0.00514	0.01	CbGeAlD
Bosutinib—MAP4K1—tendon—otosclerosis	0.00509	0.00996	CbGeAlD
Bosutinib—HCK—Focal Adhesion—RELN—otosclerosis	0.00509	0.0104	CbGpPWpGaD
Bosutinib—BTK—tendon—otosclerosis	0.00507	0.00991	CbGeAlD
Bosutinib—CASK—Non-integrin membrane-ECM interactions—TGFB1—otosclerosis	0.00501	0.0103	CbGpPWpGaD
Bosutinib—SRC—Nanoparticle-mediated activation of receptor signaling—COL1A1—otosclerosis	0.00499	0.0102	CbGpPWpGaD
Bosutinib—PDGFRB—Beta3 integrin cell surface interactions—COL1A1—otosclerosis	0.00498	0.0102	CbGpPWpGaD
Bosutinib—MAP4K2—tendon—otosclerosis	0.00493	0.00963	CbGeAlD
Bosutinib—EPHB4—connective tissue—otosclerosis	0.00491	0.00959	CbGeAlD
Bosutinib—PTK2—Integrins in angiogenesis—COL1A1—otosclerosis	0.00489	0.01	CbGpPWpGaD
Bosutinib—ERBB4—tendon—otosclerosis	0.00486	0.0095	CbGeAlD
Bosutinib—STK3—tendon—otosclerosis	0.00486	0.0095	CbGeAlD
Bosutinib—FYN—connective tissue—otosclerosis	0.00481	0.0094	CbGeAlD
Bosutinib—BMPR2—tendon—otosclerosis	0.00466	0.00911	CbGeAlD
Bosutinib—STK36—tendon—otosclerosis	0.00462	0.00903	CbGeAlD
Bosutinib—BLK—Focal Adhesion—RELN—otosclerosis	0.00461	0.00944	CbGpPWpGaD
Bosutinib—FGR—Focal Adhesion—RELN—otosclerosis	0.00459	0.0094	CbGpPWpGaD
Bosutinib—MERTK—tendon—otosclerosis	0.00457	0.00893	CbGeAlD
Bosutinib—ROCK1—Focal Adhesion—RELN—otosclerosis	0.00455	0.00931	CbGpPWpGaD
Bosutinib—MAP4K4—tendon—otosclerosis	0.00448	0.00876	CbGeAlD
Bosutinib—BCR—tendon—otosclerosis	0.00445	0.0087	CbGeAlD
Bosutinib—MAP3K12—tendon—otosclerosis	0.00442	0.00864	CbGeAlD
Bosutinib—MAP2K5—Focal Adhesion—RELN—otosclerosis	0.00438	0.00897	CbGpPWpGaD
Bosutinib—YES1—connective tissue—otosclerosis	0.00434	0.00848	CbGeAlD
Bosutinib—STK35—tendon—otosclerosis	0.00433	0.00846	CbGeAlD
Bosutinib—CSK—tendon—otosclerosis	0.0043	0.00841	CbGeAlD
Bosutinib—TAOK3—connective tissue—otosclerosis	0.00428	0.00837	CbGeAlD
Bosutinib—CSNK1A1—tendon—otosclerosis	0.00427	0.00835	CbGeAlD
Bosutinib—HCK—tendon—otosclerosis	0.00425	0.0083	CbGeAlD
Bosutinib—CLK1—tendon—otosclerosis	0.00425	0.0083	CbGeAlD
Bosutinib—ABL2—tendon—otosclerosis	0.00422	0.00825	CbGeAlD
Bosutinib—SRC—connective tissue—otosclerosis	0.00417	0.00816	CbGeAlD
Bosutinib—CAMK2G—tendon—otosclerosis	0.00417	0.00815	CbGeAlD
Bosutinib—BMP2K—tendon—otosclerosis	0.00417	0.00815	CbGeAlD
Bosutinib—EPHB2—Syndecan-2-mediated signaling events—TGFB1—otosclerosis	0.00416	0.00851	CbGpPWpGaD
Bosutinib—LRRK2—tendon—otosclerosis	0.00413	0.00808	CbGeAlD
Bosutinib—CASK—Extracellular matrix organization—COL1A1—otosclerosis	0.00405	0.0083	CbGpPWpGaD
Bosutinib—FES—Interleukin-11 Signaling Pathway—TGFB1—otosclerosis	0.00404	0.00828	CbGpPWpGaD
Bosutinib—PTK2B—tendon—otosclerosis	0.00403	0.00787	CbGeAlD
Bosutinib—CSNK1E—tendon—otosclerosis	0.00396	0.00774	CbGeAlD
Bosutinib—SIK1—tendon—otosclerosis	0.0039	0.00762	CbGeAlD
Bosutinib—IRAK4—tendon—otosclerosis	0.0039	0.00762	CbGeAlD
Bosutinib—EPHA4—tendon—otosclerosis	0.00386	0.00754	CbGeAlD
Bosutinib—ULK3—tendon—otosclerosis	0.00381	0.00745	CbGeAlD
Bosutinib—MAP2K2—tendon—otosclerosis	0.00381	0.00745	CbGeAlD
Bosutinib—HCK—Glypican 1 network—TGFB1—otosclerosis	0.00381	0.0078	CbGpPWpGaD
Bosutinib—PTK2—Focal Adhesion—RELN—otosclerosis	0.00376	0.0077	CbGpPWpGaD
Bosutinib—MAP3K7—tendon—otosclerosis	0.00375	0.00733	CbGeAlD
Bosutinib—CSF1R—connective tissue—otosclerosis	0.00375	0.00732	CbGeAlD
Bosutinib—TBK1—tendon—otosclerosis	0.00371	0.00725	CbGeAlD
Bosutinib—PTK2—tendon—otosclerosis	0.00371	0.00725	CbGeAlD
Bosutinib—IRAK1—tendon—otosclerosis	0.00363	0.0071	CbGeAlD
Bosutinib—RPS6KB1—tendon—otosclerosis	0.00357	0.00697	CbGeAlD
Bosutinib—LRRK2—Allograft Rejection—TGFB1—otosclerosis	0.00355	0.00727	CbGpPWpGaD
Bosutinib—FGR—tendon—otosclerosis	0.00354	0.00693	CbGeAlD
Bosutinib—AXL—tendon—otosclerosis	0.00353	0.0069	CbGeAlD
Bosutinib—BLK—Glypican 1 network—TGFB1—otosclerosis	0.00345	0.00707	CbGpPWpGaD
Bosutinib—FGR—Glypican 1 network—TGFB1—otosclerosis	0.00344	0.00704	CbGpPWpGaD
Bosutinib—SLK—tendon—otosclerosis	0.0034	0.00664	CbGeAlD
Bosutinib—EPHB4—tendon—otosclerosis	0.00337	0.00659	CbGeAlD
Bosutinib—PDGFRB—connective tissue—otosclerosis	0.00332	0.0065	CbGeAlD
Bosutinib—EPHA2—tendon—otosclerosis	0.00331	0.00647	CbGeAlD
Bosutinib—FYN—tendon—otosclerosis	0.0033	0.00646	CbGeAlD
Bosutinib—IKBKE—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.00329	0.00673	CbGpPWpGaD
Bosutinib—RPS6KB1—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—otosclerosis	0.00328	0.00672	CbGpPWpGaD
Bosutinib—MAP3K3—tendon—otosclerosis	0.00323	0.00631	CbGeAlD
Bosutinib—MAP4K5—tendon—otosclerosis	0.00323	0.00631	CbGeAlD
Bosutinib—SYK—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00315	0.00646	CbGpPWpGaD
Bosutinib—CSF1R—Differentiation Pathway—TGFB1—otosclerosis	0.00304	0.00622	CbGpPWpGaD
Bosutinib—YES1—tendon—otosclerosis	0.00298	0.00583	CbGeAlD
Bosutinib—ABL1—connective tissue—otosclerosis	0.00296	0.00579	CbGeAlD
Bosutinib—STK10—tendon—otosclerosis	0.00296	0.00578	CbGeAlD
Bosutinib—TAOK3—tendon—otosclerosis	0.00294	0.00575	CbGeAlD
Bosutinib—MAP2K2—Focal Adhesion—RELN—otosclerosis	0.00289	0.00592	CbGpPWpGaD
Bosutinib—PDGFRB—Focal Adhesion—RELN—otosclerosis	0.00282	0.00578	CbGpPWpGaD
Bosutinib—YES1—Glypican 1 network—TGFB1—otosclerosis	0.00278	0.00569	CbGpPWpGaD
Bosutinib—HCK—Focal Adhesion—COL1A1—otosclerosis	0.00273	0.0056	CbGpPWpGaD
Bosutinib—MAP4K1—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.00273	0.00558	CbGpPWpGaD
Bosutinib—FYN—Focal Adhesion—RELN—otosclerosis	0.00272	0.00557	CbGpPWpGaD
Bosutinib—MAP2K1—Focal Adhesion—RELN—otosclerosis	0.00271	0.00554	CbGpPWpGaD
Bosutinib—SIK1—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.00264	0.00541	CbGpPWpGaD
Bosutinib—MAP2K5—tendon—otosclerosis	0.00264	0.00516	CbGeAlD
Bosutinib—SRC—Integrins in angiogenesis—COL1A1—otosclerosis	0.00261	0.00534	CbGpPWpGaD
Bosutinib—CSF1R—tendon—otosclerosis	0.00258	0.00503	CbGeAlD
Bosutinib—BLK—Focal Adhesion—COL1A1—otosclerosis	0.00248	0.00507	CbGpPWpGaD
Bosutinib—FGR—Focal Adhesion—COL1A1—otosclerosis	0.00247	0.00505	CbGpPWpGaD
Bosutinib—ROCK1—Focal Adhesion—COL1A1—otosclerosis	0.00244	0.005	CbGpPWpGaD
Bosutinib—MAP2K5—Focal Adhesion—COL1A1—otosclerosis	0.00236	0.00482	CbGpPWpGaD
Bosutinib—EGFR—Focal Adhesion—RELN—otosclerosis	0.00235	0.00481	CbGpPWpGaD
Bosutinib—IKBKE—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—otosclerosis	0.00234	0.0048	CbGpPWpGaD
Bosutinib—MAP2K1—Senescence and Autophagy in Cancer—COL1A1—otosclerosis	0.00234	0.00479	CbGpPWpGaD
Bosutinib—HCK—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00229	0.0047	CbGpPWpGaD
Bosutinib—PDGFRB—tendon—otosclerosis	0.00228	0.00446	CbGeAlD
Bosutinib—WEE1—Cell Cycle—TGFB1—otosclerosis	0.00223	0.00457	CbGpPWpGaD
Bosutinib—STK3—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00218	0.00446	CbGpPWpGaD
Bosutinib—RPS6KB1—Interleukin-11 Signaling Pathway—TGFB1—otosclerosis	0.00215	0.00441	CbGpPWpGaD
Bosutinib—PKMYT1—Cell Cycle—TGFB1—otosclerosis	0.00213	0.00435	CbGpPWpGaD
Bosutinib—LYN—Glypican 1 network—TGFB1—otosclerosis	0.00207	0.00424	CbGpPWpGaD
Bosutinib—FYN—Glypican 1 network—TGFB1—otosclerosis	0.00204	0.00417	CbGpPWpGaD
Bosutinib—ABL1—tendon—otosclerosis	0.00204	0.00398	CbGeAlD
Bosutinib—PTK2—Focal Adhesion—COL1A1—otosclerosis	0.00202	0.00414	CbGpPWpGaD
Bosutinib—SRC—Focal Adhesion—RELN—otosclerosis	0.00201	0.00411	CbGpPWpGaD
Bosutinib—MAP3K12—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00194	0.00398	CbGpPWpGaD
Bosutinib—LRRK2—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00194	0.00398	CbGpPWpGaD
Bosutinib—PRKCQ—TCR Signaling Pathway—TGFB1—otosclerosis	0.0019	0.0039	CbGpPWpGaD
Bosutinib—RPS6KB1—TGF-beta receptor signaling—TGFB1—otosclerosis	0.00188	0.00386	CbGpPWpGaD
Bosutinib—PRKCQ—Corticotropin-releasing hormone—TGFB1—otosclerosis	0.00187	0.00383	CbGpPWpGaD
Bosutinib—MAP4K1—TCR Signaling Pathway—TGFB1—otosclerosis	0.00184	0.00376	CbGpPWpGaD
Bosutinib—YES1—Interleukin-11 Signaling Pathway—TGFB1—otosclerosis	0.00182	0.00373	CbGpPWpGaD
Bosutinib—MAP2K5—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.0018	0.00369	CbGpPWpGaD
Bosutinib—SRC—Senescence and Autophagy in Cancer—COL1A1—otosclerosis	0.00173	0.00355	CbGpPWpGaD
Bosutinib—LCK—Glypican 1 network—TGFB1—otosclerosis	0.0017	0.00347	CbGpPWpGaD
Bosutinib—EPHA4—Spinal Cord Injury—TGFB1—otosclerosis	0.00166	0.0034	CbGpPWpGaD
Bosutinib—MAP4K4—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00165	0.00338	CbGpPWpGaD
Bosutinib—CHEK2—Cell Cycle—TGFB1—otosclerosis	0.00162	0.00332	CbGpPWpGaD
Bosutinib—EGFR—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—otosclerosis	0.00157	0.00322	CbGpPWpGaD
Bosutinib—MAP2K2—Focal Adhesion—COL1A1—otosclerosis	0.00156	0.00318	CbGpPWpGaD
Bosutinib—RPS6KB1—Regulation of Telomerase—TGFB1—otosclerosis	0.00152	0.00311	CbGpPWpGaD
Bosutinib—PDGFRB—Focal Adhesion—COL1A1—otosclerosis	0.00152	0.00311	CbGpPWpGaD
Bosutinib—SRC—Glypican 1 network—TGFB1—otosclerosis	0.0015	0.00308	CbGpPWpGaD
Bosutinib—EPHA3—NRF2 pathway—TGFB1—otosclerosis	0.00147	0.00301	CbGpPWpGaD
Bosutinib—CDK2—Cell Cycle—TGFB1—otosclerosis	0.00146	0.003	CbGpPWpGaD
Bosutinib—FYN—Focal Adhesion—COL1A1—otosclerosis	0.00146	0.003	CbGpPWpGaD
Bosutinib—MAP2K1—Focal Adhesion—COL1A1—otosclerosis	0.00145	0.00298	CbGpPWpGaD
Bosutinib—PDGFRB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—otosclerosis	0.00144	0.00295	CbGpPWpGaD
Bosutinib—MAP3K7—TGF-beta receptor signaling—TGFB1—otosclerosis	0.00142	0.00292	CbGpPWpGaD
Bosutinib—MAP2K2—Interleukin-11 Signaling Pathway—TGFB1—otosclerosis	0.00142	0.00291	CbGpPWpGaD
Bosutinib—MAP3K7—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.00136	0.00279	CbGpPWpGaD
Bosutinib—MAP4K1—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.00135	0.00277	CbGpPWpGaD
Bosutinib—FYN—Interleukin-11 Signaling Pathway—TGFB1—otosclerosis	0.00134	0.00274	CbGpPWpGaD
Bosutinib—ROCK1—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—otosclerosis	0.00133	0.00273	CbGpPWpGaD
Bosutinib—MAP2K1—Interleukin-11 Signaling Pathway—TGFB1—otosclerosis	0.00133	0.00273	CbGpPWpGaD
Bosutinib—PTK2B—TCR Signaling Pathway—TGFB1—otosclerosis	0.00131	0.00268	CbGpPWpGaD
Bosutinib—CDK2—Spinal Cord Injury—TGFB1—otosclerosis	0.0013	0.00267	CbGpPWpGaD
Bosutinib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—otosclerosis	0.00128	0.00263	CbGpPWpGaD
Bosutinib—EGFR—Focal Adhesion—COL1A1—otosclerosis	0.00126	0.00259	CbGpPWpGaD
Bosutinib—LYN—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00125	0.00255	CbGpPWpGaD
Bosutinib—PTK2—Primary Focal Segmental Glomerulosclerosis FSGS—TGFB1—otosclerosis	0.00125	0.00255	CbGpPWpGaD
Bosutinib—FYN—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00123	0.00251	CbGpPWpGaD
Bosutinib—MAP2K1—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00122	0.0025	CbGpPWpGaD
Bosutinib—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—otosclerosis	0.0012	0.00246	CbGpPWpGaD
Bosutinib—MAP2K2—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.00119	0.00244	CbGpPWpGaD
Bosutinib—SRC—Syndecan-2-mediated signaling events—TGFB1—otosclerosis	0.00116	0.00237	CbGpPWpGaD
Bosutinib—CASK—Extracellular matrix organization—TGFB1—otosclerosis	0.00115	0.00236	CbGpPWpGaD
Bosutinib—EPHA2—NRF2 pathway—TGFB1—otosclerosis	0.00114	0.00234	CbGpPWpGaD
Bosutinib—EGFR—Aryl Hydrocarbon Receptor Pathway—TGFB1—otosclerosis	0.00112	0.00228	CbGpPWpGaD
Bosutinib—MAP4K1—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00112	0.00228	CbGpPWpGaD
Bosutinib—MAP3K2—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00112	0.00228	CbGpPWpGaD
Bosutinib—MAP2K1—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.00111	0.00228	CbGpPWpGaD
Bosutinib—SRC—Focal Adhesion—COL1A1—otosclerosis	0.00108	0.00221	CbGpPWpGaD
Bosutinib—MERTK—Hemostasis—TGFB1—otosclerosis	0.00106	0.00217	CbGpPWpGaD
Bosutinib—PTK2—Corticotropin-releasing hormone—TGFB1—otosclerosis	0.00102	0.0021	CbGpPWpGaD
Bosutinib—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—otosclerosis	0.00102	0.0021	CbGpPWpGaD
Bosutinib—SRC—Interleukin-11 Signaling Pathway—TGFB1—otosclerosis	0.000986	0.00202	CbGpPWpGaD
Bosutinib—CHEK2—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000983	0.00201	CbGpPWpGaD
Bosutinib—ABL1—Regulation of Telomerase—TGFB1—otosclerosis	0.000955	0.00196	CbGpPWpGaD
Bosutinib—SRC—Aryl Hydrocarbon Receptor Pathway—TGFB1—otosclerosis	0.000952	0.00195	CbGpPWpGaD
Bosutinib—SYK—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000945	0.00193	CbGpPWpGaD
Bosutinib—ROCK1—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.000929	0.0019	CbGpPWpGaD
Bosutinib—PRKCQ—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000928	0.0019	CbGpPWpGaD
Bosutinib—MAP3K7—TCR Signaling Pathway—TGFB1—otosclerosis	0.000918	0.00188	CbGpPWpGaD
Bosutinib—SRC—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.000905	0.00185	CbGpPWpGaD
Bosutinib—FYN—Primary Focal Segmental Glomerulosclerosis FSGS—TGFB1—otosclerosis	0.000902	0.00185	CbGpPWpGaD
Bosutinib—CSK—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000896	0.00183	CbGpPWpGaD
Bosutinib—CDK2—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000886	0.00181	CbGpPWpGaD
Bosutinib—MAP2K2—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—otosclerosis	0.000848	0.00174	CbGpPWpGaD
Bosutinib—EGFR—Regulation of Telomerase—TGFB1—otosclerosis	0.000816	0.00167	CbGpPWpGaD
Bosutinib—MAP2K2—TCR Signaling Pathway—TGFB1—otosclerosis	0.000803	0.00164	CbGpPWpGaD
Bosutinib—MAP2K1—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—otosclerosis	0.000793	0.00162	CbGpPWpGaD
Bosutinib—MAP3K7—DNA Damage Response (only ATM dependent)—TGFB1—otosclerosis	0.000788	0.00161	CbGpPWpGaD
Bosutinib—PTK2—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.000768	0.00157	CbGpPWpGaD
Bosutinib—FYN—TCR Signaling Pathway—TGFB1—otosclerosis	0.000755	0.00155	CbGpPWpGaD
Bosutinib—MAP2K1—TCR Signaling Pathway—TGFB1—otosclerosis	0.000751	0.00154	CbGpPWpGaD
Bosutinib—MAP2K1—Corticotropin-releasing hormone—TGFB1—otosclerosis	0.000738	0.00151	CbGpPWpGaD
Bosutinib—MAP2K5—MAPK Signaling Pathway—TGFB1—otosclerosis	0.000738	0.00151	CbGpPWpGaD
Bosutinib—ABL1—Cell Cycle—TGFB1—otosclerosis	0.00069	0.00141	CbGpPWpGaD
Bosutinib—MAP3K7—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.000676	0.00138	CbGpPWpGaD
Bosutinib—MAP2K1—Senescence and Autophagy in Cancer—TGFB1—otosclerosis	0.000664	0.00136	CbGpPWpGaD
Bosutinib—ABL1—DNA Damage Response (only ATM dependent)—TGFB1—otosclerosis	0.000655	0.00134	CbGpPWpGaD
Bosutinib—EPHB3—Developmental Biology—TGFB1—otosclerosis	0.000621	0.00127	CbGpPWpGaD
Bosutinib—WEE1—Hemostasis—TGFB1—otosclerosis	0.00062	0.00127	CbGpPWpGaD
Bosutinib—MAP2K2—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.000591	0.00121	CbGpPWpGaD
Bosutinib—FES—Developmental Biology—TGFB1—otosclerosis	0.000584	0.0012	CbGpPWpGaD
Bosutinib—MAP3K7—MAPK Signaling Pathway—TGFB1—otosclerosis	0.000557	0.00114	CbGpPWpGaD
Bosutinib—EPHA5—Developmental Biology—TGFB1—otosclerosis	0.000554	0.00113	CbGpPWpGaD
Bosutinib—EPHA3—Developmental Biology—TGFB1—otosclerosis	0.000554	0.00113	CbGpPWpGaD
Bosutinib—ABL2—Developmental Biology—TGFB1—otosclerosis	0.000554	0.00113	CbGpPWpGaD
Bosutinib—MAP2K1—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.000553	0.00113	CbGpPWpGaD
Bosutinib—EPHA8—Developmental Biology—TGFB1—otosclerosis	0.000534	0.00109	CbGpPWpGaD
Bosutinib—EPHA4—Developmental Biology—TGFB1—otosclerosis	0.000528	0.00108	CbGpPWpGaD
Bosutinib—EPHB4—Developmental Biology—TGFB1—otosclerosis	0.000528	0.00108	CbGpPWpGaD
Bosutinib—EGFR—Spinal Cord Injury—TGFB1—otosclerosis	0.000525	0.00108	CbGpPWpGaD
Bosutinib—EPHB2—Developmental Biology—TGFB1—otosclerosis	0.000511	0.00105	CbGpPWpGaD
Bosutinib—PTK2—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000508	0.00104	CbGpPWpGaD
Bosutinib—SRC—Senescence and Autophagy in Cancer—TGFB1—otosclerosis	0.000492	0.00101	CbGpPWpGaD
Bosutinib—PRKCQ—Developmental Biology—TGFB1—otosclerosis	0.000487	0.000998	CbGpPWpGaD
Bosutinib—MAP2K2—MAPK Signaling Pathway—TGFB1—otosclerosis	0.000487	0.000997	CbGpPWpGaD
Bosutinib—SYK—Hemostasis—TGFB1—otosclerosis	0.000487	0.000997	CbGpPWpGaD
Bosutinib—PRKCQ—Hemostasis—TGFB1—otosclerosis	0.000478	0.000979	CbGpPWpGaD
Bosutinib—PDGFRB—MAPK Signaling Pathway—TGFB1—otosclerosis	0.000475	0.000973	CbGpPWpGaD
Bosutinib—CSK—Hemostasis—TGFB1—otosclerosis	0.000462	0.000945	CbGpPWpGaD
Bosutinib—MAP2K1—MAPK Signaling Pathway—TGFB1—otosclerosis	0.000456	0.000933	CbGpPWpGaD
Bosutinib—EPHA2—Developmental Biology—TGFB1—otosclerosis	0.000431	0.000881	CbGpPWpGaD
Bosutinib—ABL1—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000418	0.000856	CbGpPWpGaD
Bosutinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000411	0.000842	CbGpPWpGaD
Bosutinib—SRC—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.00041	0.000839	CbGpPWpGaD
Bosutinib—CDK2—Hemostasis—TGFB1—otosclerosis	0.000407	0.000832	CbGpPWpGaD
Bosutinib—EGFR—MAPK Signaling Pathway—TGFB1—otosclerosis	0.000396	0.00081	CbGpPWpGaD
Bosutinib—PHKG1—Disease—TGFB1—otosclerosis	0.000389	0.000797	CbGpPWpGaD
Bosutinib—LYN—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000374	0.000765	CbGpPWpGaD
Bosutinib—FYN—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000368	0.000753	CbGpPWpGaD
Bosutinib—ABCB1—Allograft Rejection—TGFB1—otosclerosis	0.000365	0.000748	CbGpPWpGaD
Bosutinib—STK4—Signaling Pathways—TGFB1—otosclerosis	0.00036	0.000736	CbGpPWpGaD
Bosutinib—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000357	0.000731	CbGpPWpGaD
Bosutinib—ROCK1—Developmental Biology—TGFB1—otosclerosis	0.000323	0.000661	CbGpPWpGaD
Bosutinib—FGR—Hemostasis—TGFB1—otosclerosis	0.00032	0.000655	CbGpPWpGaD
Bosutinib—BCR—Disease—TGFB1—otosclerosis	0.000317	0.00065	CbGpPWpGaD
Bosutinib—LCK—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000306	0.000627	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—TGFB1—otosclerosis	0.000306	0.000626	CbGpPWpGaD
Bosutinib—SRC—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000305	0.000624	CbGpPWpGaD
Bosutinib—SRC—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000271	0.000555	CbGpPWpGaD
Bosutinib—PTK2—Developmental Biology—TGFB1—otosclerosis	0.000267	0.000547	CbGpPWpGaD
Bosutinib—YES1—Developmental Biology—TGFB1—otosclerosis	0.000263	0.000539	CbGpPWpGaD
Bosutinib—PTK2—Hemostasis—TGFB1—otosclerosis	0.000262	0.000536	CbGpPWpGaD
Bosutinib—YES1—Hemostasis—TGFB1—otosclerosis	0.000258	0.000529	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—TGFB1—otosclerosis	0.000256	0.000525	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—TGFB1—otosclerosis	0.000243	0.000497	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—TGFB1—otosclerosis	0.000232	0.000475	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—TGFB1—otosclerosis	0.000231	0.000474	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—TGFB1—otosclerosis	0.000231	0.000474	CbGpPWpGaD
Bosutinib—CSK—Disease—TGFB1—otosclerosis	0.000224	0.000458	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—TGFB1—otosclerosis	0.000222	0.000455	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—TGFB1—otosclerosis	0.000206	0.000421	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—TGFB1—otosclerosis	0.000196	0.000402	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—TGFB1—otosclerosis	0.000195	0.0004	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—TGFB1—otosclerosis	0.000194	0.000398	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—TGFB1—otosclerosis	0.000193	0.000396	CbGpPWpGaD
Bosutinib—LYN—Hemostasis—TGFB1—otosclerosis	0.000193	0.000394	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—TGFB1—otosclerosis	0.000192	0.000394	CbGpPWpGaD
Bosutinib—ABL1—Hemostasis—TGFB1—otosclerosis	0.000192	0.000393	CbGpPWpGaD
Bosutinib—FYN—Hemostasis—TGFB1—otosclerosis	0.00019	0.000388	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—TGFB1—otosclerosis	0.000187	0.000383	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.00018	0.000369	CbGpPWpGaD
Bosutinib—HCK—Disease—TGFB1—otosclerosis	0.000172	0.000351	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—TGFB1—otosclerosis	0.000167	0.000342	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—TGFB1—otosclerosis	0.000165	0.000338	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—TGFB1—otosclerosis	0.000162	0.000332	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—TGFB1—otosclerosis	0.000162	0.000332	CbGpPWpGaD
Bosutinib—ERBB4—Disease—TGFB1—otosclerosis	0.000162	0.000331	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—TGFB1—otosclerosis	0.000158	0.000323	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—TGFB1—otosclerosis	0.000157	0.000321	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—TGFB1—otosclerosis	0.000142	0.000292	CbGpPWpGaD
Bosutinib—ERBB3—Disease—TGFB1—otosclerosis	0.000142	0.000292	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—TGFB1—otosclerosis	0.00014	0.000286	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—TGFB1—otosclerosis	0.000131	0.000268	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TGFB1—otosclerosis	0.000113	0.000232	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TGFB1—otosclerosis	0.000112	0.000228	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TGFB1—otosclerosis	0.000107	0.00022	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TGFB1—otosclerosis	0.000104	0.000212	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TGFB1—otosclerosis	0.000104	0.000212	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TGFB1—otosclerosis	9.98e-05	0.000204	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—TGFB1—otosclerosis	9.76e-05	0.0002	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—TGFB1—otosclerosis	9.53e-05	0.000195	CbGpPWpGaD
Bosutinib—FYN—Disease—TGFB1—otosclerosis	9.18e-05	0.000188	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—TGFB1—otosclerosis	9.13e-05	0.000187	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TGFB1—otosclerosis	8.88e-05	0.000182	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TGFB1—otosclerosis	8.76e-05	0.000179	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TGFB1—otosclerosis	8.31e-05	0.00017	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFB1—otosclerosis	7.93e-05	0.000162	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFB1—otosclerosis	7.82e-05	0.00016	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFB1—otosclerosis	7.64e-05	0.000157	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFB1—otosclerosis	6.84e-05	0.00014	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFB1—otosclerosis	6.77e-05	0.000139	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFB1—otosclerosis	6.67e-05	0.000137	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFB1—otosclerosis	6.53e-05	0.000134	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFB1—otosclerosis	6.43e-05	0.000132	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFB1—otosclerosis	6.4e-05	0.000131	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFB1—otosclerosis	5.55e-05	0.000114	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFB1—otosclerosis	5.35e-05	0.00011	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFB1—otosclerosis	4.74e-05	9.7e-05	CbGpPWpGaD
